1 |
MAPK14
| 23件: Rap1 signaling pathway Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Retrograde endocannabinoid signaling, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Relaxin signaling pathway, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer | D09639
D09639
|
Losmapimod
| 2件: 113 113, 222 |
2 |
MAPK14
| 23件: Rap1 signaling pathway Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Retrograde endocannabinoid signaling, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Relaxin signaling pathway, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer | D10959
D10959
|
Neflamapimod
| 1件: 8 8 |
3 |
F2
| 2件: Platelet activation Platelet activation, Regulation of actin cytoskeleton | D06410
D06410
|
Thrombomodulin Alfa
| 1件: 85 85 |
4 |
F2
| 2件: Platelet activation Platelet activation, Regulation of actin cytoskeleton | D07144
D07144
|
Dabigatran etexilate
| 2件: 51 51, 75 |
5 |
F2
| 2件: Platelet activation Platelet activation, Regulation of actin cytoskeleton | D09707
D09707
|
Dabigatran
| 5件: 51 51, 75, 85, 91, 124 |
6 |
FYN
| 5件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Platelet activation, T cell receptor signaling pathway, Prion disease, Viral myocarditis | D03658
D03658
|
Dasatinib
| 2件: 51 51, 85 |
7 |
FYN
| 5件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Platelet activation, T cell receptor signaling pathway, Prion disease, Viral myocarditis | D06414
D06414
|
Dasatinib
| 2件: 51 51, 85 |
8 |
GUCY1A2
| 5件: Purine metabolism Purine metabolism, Vascular smooth muscle contraction, Platelet activation, Renin secretion, Salivary secretion | D00517
D00517
|
Amyl Nitrite
| 1件: 58 58 |
9 |
GUCY1A2
| 5件: Purine metabolism Purine metabolism, Vascular smooth muscle contraction, Platelet activation, Renin secretion, Salivary secretion | D09572
D09572
|
Riociguat
| 6件: 51 51, 84, 86, 88, 225, 299 |
10 |
GUCY1A1
| 5件: Purine metabolism Purine metabolism, Vascular smooth muscle contraction, Platelet activation, Renin secretion, Salivary secretion | D00517
D00517
|
Amyl Nitrite
| 1件: 58 58 |
11 |
GUCY1A1
| 5件: Purine metabolism Purine metabolism, Vascular smooth muscle contraction, Platelet activation, Renin secretion, Salivary secretion | D09572
D09572
|
Riociguat
| 6件: 51 51, 84, 86, 88, 225, 299 |
12 |
GUCY1B1
| 5件: Purine metabolism Purine metabolism, Vascular smooth muscle contraction, Platelet activation, Renin secretion, Salivary secretion | D00517
D00517
|
Amyl Nitrite
| 1件: 58 58 |
13 |
GUCY1B1
| 5件: Purine metabolism Purine metabolism, Vascular smooth muscle contraction, Platelet activation, Renin secretion, Salivary secretion | D09572
D09572
|
Riociguat
| 6件: 51 51, 84, 86, 88, 225, 299 |
14 |
PIK3CA
| 27件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11011
D11011
|
Alpelisib
| 1件: 138 138 |
15 |
PIK3CA
| 27件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
16 |
PIK3CB
| 27件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
17 |
PIK3CD
| 27件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
18 |
PIK3CD
| 27件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11437
D11437
|
Parsaclisib
| 3件: 35 35, 53, 61 |
19 |
MAPK11
| 23件: Rap1 signaling pathway Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Retrograde endocannabinoid signaling, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Relaxin signaling pathway, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer | D09639
D09639
|
Losmapimod
| 2件: 113 113, 222 |
20 |
MAPK11
| 23件: Rap1 signaling pathway Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Retrograde endocannabinoid signaling, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Relaxin signaling pathway, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer | D10959
D10959
|
Neflamapimod
| 1件: 8 8 |
21 |
MAPK13
| 23件: Rap1 signaling pathway Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Retrograde endocannabinoid signaling, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Relaxin signaling pathway, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer | D09639
D09639
|
Losmapimod
| 2件: 113 113, 222 |
22 |
MAPK13
| 23件: Rap1 signaling pathway Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Retrograde endocannabinoid signaling, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Relaxin signaling pathway, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer | D10959
D10959
|
Neflamapimod
| 1件: 8 8 |
23 |
PTGIR
| 2件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Platelet activation | D00106
D00106
|
Epoprostenol
| 1件: 86 86 |
24 |
PTGIR
| 2件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Platelet activation | D01385
D01385
|
Ibudilast
| 2件: 2 2, 13 |
25 |
PTGIR
| 2件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Platelet activation | D02720
D02720
|
Beraprost
| 1件: 86 86 |
26 |
PTGIR
| 2件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Platelet activation | D02721
D02721
|
Iloprost
| 4件: 51 51, 84, 85, 86 |
27 |
PTGIR
| 2件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Platelet activation | D06213
D06213
|
Treprostinil
| 6件: 51 51, 84, 85, 86, 88, 210 |
28 |
PTGIR
| 2件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Platelet activation | D09994
D09994
|
Selexipag
| 5件: 51 51, 70, 84, 86, 88 |
29 |
PTGIR
| 2件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Platelet activation | D10725
D10725
|
Ralinepag
| 1件: 86 86 |
30 |
PTGS1
| 3件: Platelet activation Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | D00109
D00109
|
Acetylsalicylic acid
| 14件: 13 13, 22, 46, 49, 51, 58, 64, 86, 97, 113, 158, 210, 231, 251 |
31 |
PTGS1
| 3件: Platelet activation Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | D00118
D00118
|
Naproxen
| 4件: 13 13, 46, 107, 271 |
32 |
PTGS1
| 3件: Platelet activation Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | D00120
D00120
|
Sulindac
| 1件: 206 206 |
33 |
PTGS1
| 3件: Platelet activation Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | D00126
D00126
|
Ibuprofen
| 7件: 13 13, 46, 65, 107, 113, 271, 299 |
34 |
PTGS1
| 3件: Platelet activation Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | D00132
D00132
|
Ketoprofen
| 1件: 46 46 |
35 |
PTGS1
| 3件: Platelet activation Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | D00141
D00141
|
Indomethacin
| 3件: 225 225, 271, 298 |
36 |
PTGS1
| 3件: Platelet activation Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | D00217
D00217
|
Acetaminophen
| 15件: 3 3, 6, 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 |
37 |
PTGS1
| 3件: Platelet activation Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | D00330
D00330
|
Flurbiprofen
| 3件: 13 13, 21, 46 |
38 |
PTGS1
| 3件: Platelet activation Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | D00428
D00428
|
Salsalate
| 1件: 5 5 |
39 |
PTGS1
| 3件: Platelet activation Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | D01183
D01183
|
Tolfenamic acid
| 1件: 5 5 |
40 |
PTGS1
| 3件: Platelet activation Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | D01545
D01545
|
Aceclofenac
| 1件: 46 46 |
41 |
PTGS1
| 3件: Platelet activation Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | D07816
D07816
|
Diclofenac
| 5件: 13 13, 34, 46, 78, 271 |
42 |
PTGS1
| 3件: Platelet activation Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | D08104
D08104
|
Ketorolac
| 2件: 70 70, 226 |
43 |
PTGS1
| 3件: Platelet activation Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | D08149
D08149
|
Loxoprofen
| 2件: 46 46, 271 |
44 |
ROCK1
| 9件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, TGF-beta signaling pathway, Tight junction, Platelet activation, Regulation of actin cytoskeleton, Shigellosis, Yersinia infection, Proteoglycans in cancer | D07941
D07941
|
Fasudil
| 4件: 2 2, 5, 7, 51 |
45 |
MAPK12
| 23件: Rap1 signaling pathway Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Retrograde endocannabinoid signaling, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Relaxin signaling pathway, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer | D09639
D09639
|
Losmapimod
| 2件: 113 113, 222 |
46 |
MAPK12
| 23件: Rap1 signaling pathway Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Retrograde endocannabinoid signaling, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Relaxin signaling pathway, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer | D10959
D10959
|
Neflamapimod
| 1件: 8 8 |
47 |
P2RY12
| 1件: Platelet activation Platelet activation | D07729
D07729
|
Clopidogrel
| 3件: 49 49, 51, 86 |
48 |
P2RY12
| 1件: Platelet activation Platelet activation | D09017
D09017
|
Ticagrelor
| 3件: 36 36, 46, 85 |
49 |
P2RY12
| 1件: Platelet activation Platelet activation | D10823
D10823
|
Clopidogrel
| 3件: 49 49, 51, 86 |
50 |
P2RY12
| 1件: Platelet activation Platelet activation | D10824
D10824
|
Clopidogrel
| 3件: 49 49, 51, 86 |
51 |
SRC
| 13件: Rap1 signaling pathway Rap1 signaling pathway, VEGF signaling pathway, Tight junction, Platelet activation, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Shigellosis, Yersinia infection, Tuberculosis, Viral carcinogenesis, Proteoglycans in cancer | D03252
D03252
|
Bosutinib
| 2件: 2 2, 67 |
52 |
SRC
| 13件: Rap1 signaling pathway Rap1 signaling pathway, VEGF signaling pathway, Tight junction, Platelet activation, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Shigellosis, Yersinia infection, Tuberculosis, Viral carcinogenesis, Proteoglycans in cancer | D03658
D03658
|
Dasatinib
| 2件: 51 51, 85 |
53 |
SRC
| 13件: Rap1 signaling pathway Rap1 signaling pathway, VEGF signaling pathway, Tight junction, Platelet activation, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Shigellosis, Yersinia infection, Tuberculosis, Viral carcinogenesis, Proteoglycans in cancer | D06414
D06414
|
Dasatinib
| 2件: 51 51, 85 |
54 |
SRC
| 13件: Rap1 signaling pathway Rap1 signaling pathway, VEGF signaling pathway, Tight junction, Platelet activation, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Shigellosis, Yersinia infection, Tuberculosis, Viral carcinogenesis, Proteoglycans in cancer | D09664
D09664
|
Saracatinib
| 3件: 6 6, 89, 272 |
55 |
SYK
| 3件: Platelet activation Platelet activation, Tuberculosis, Viral carcinogenesis | D09347
D09347
|
Fostamatinib
| 4件: 46 46, 49, 61, 66 |
56 |
TBXA2R
| 1件: Platelet activation Platelet activation | D01128
D01128
|
Ramatroban
| 1件: 13 13 |
57 |
TBXA2R
| 1件: Platelet activation Platelet activation | D01896
D01896
|
Cilostazol
| 3件: 46 46, 51, 70 |
58 |
TBXA2R
| 1件: Platelet activation Platelet activation | D04500
D04500
|
Ifetroban
| 2件: 85 85, 113 |
59 |
BTK
| 2件: Platelet activation Platelet activation, Primary immunodeficiency | D10223
D10223
|
Ibrutinib
| 3件: 28 28, 60, 61 |
60 |
BTK
| 2件: Platelet activation Platelet activation, Primary immunodeficiency | D10893
D10893
|
Acalabrutinib
| 2件: 46 46, 61 |
61 |
BTK
| 2件: Platelet activation Platelet activation, Primary immunodeficiency | D11422
D11422
|
Zanubrutinib
| 5件: 13 13, 63, 222, 300, 331 |
62 |
BTK
| 2件: Platelet activation Platelet activation, Primary immunodeficiency | D11457
D11457
|
Fenebrutinib
| 1件: 13 13 |
63 |
BTK
| 2件: Platelet activation Platelet activation, Primary immunodeficiency | D11478
D11478
|
Branebrutinib
| 3件: 46 46, 49, 53 |
64 |
BTK
| 2件: Platelet activation Platelet activation, Primary immunodeficiency | D12160
D12160
|
Orelabrutinib
| 4件: 13 13, 49, 61, 63 |
65 |
BTK
| 2件: Platelet activation Platelet activation, Primary immunodeficiency | D12285
D12285
|
Remibrutinib
| 2件: 13 13, 53 |
66 |
BTK
| 2件: Platelet activation Platelet activation, Primary immunodeficiency | D12467
D12467
|
Evobrutinib
| 3件: 13 13, 46, 49 |
67 |
VWF
| 1件: Platelet activation Platelet activation | D11160
D11160
|
Caplacizumab
| 1件: 64 64 |
68 |
ROCK2
| 10件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, Wnt signaling pathway, Tight junction, Platelet activation, Regulation of actin cytoskeleton, Shigellosis, Salmonella infection, Yersinia infection, Proteoglycans in cancer | D07941
D07941
|
Fasudil
| 4件: 2 2, 5, 7, 51 |
69 |
ROCK2
| 10件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, Wnt signaling pathway, Tight junction, Platelet activation, Regulation of actin cytoskeleton, Shigellosis, Salmonella infection, Yersinia infection, Proteoglycans in cancer | D11815
D11815
|
Belumosudil
| 2件: 51 51, 85 |